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Abstract
Background: Changes in maximum standardised uptake values (SUVmax) between serial PET/CT studies are used to
determine disease progression or regression in oncologic patients. To measure these changes manually can be
time consuming in a clinical routine. A semi-automatic method for calculation of SUVmax in serial PET/CT studies
was developed and compared to a conventional manual method. The semi-automatic method first aligns the serial
PET/CT studies based on the CT images. Thereafter, the reader selects an abnormal lesion in one of the PET
studies. After this manual step, the program automatically detects the corresponding lesion in the other PET study,
segments the two lesions and calculates the SUVmax in both studies as well as the difference between the SUVmax
values. The results of the semi-automatic analysis were compared to that of a manual SUVmax analysis using a
Philips PET/CT workstation. Three readers did the SUVmax readings in both methods. Sixteen patients with lung
cancer or lymphoma who had undergone two PET/CT studies were included. There were a total of 26 lesions.
Results: Linear regression analysis of changes in SUVmax show that intercepts and slopes are close to the line of
identity for all readers (reader 1: intercept = 1.02, R
2 = 0.96; reader 2: intercept = 0.97, R
2 = 0.98; reader 3: intercept
= 0.99, R
2 = 0.98). Manual and semi-automatic method agreed in all cases whether SUVmax had increased or
decreased between the serial studies. The average time to measure SUVmax changes in two serial PET/CT
examinations was four to five times longer for the manual method compared to the semi-automatic method for
all readers (reader 1: 53.7 vs. 10.5 s; reader 2: 27.3 vs. 6.9 s; reader 3: 47.5 vs. 9.5 s; p < 0.001 for all).
Conclusions: Good agreement was shown in assessment of SUVmax changes between manual and semi-automatic
method. The semi-automatic analysis was four to five times faster to perform than the manual analysis. These
findings show the feasibility of using semi-automatic methods for calculation of SUVmax in clinical routine and
encourage further development of programs using this type of methods.
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Background
Changes in maximum standard uptake values (SUVmax)
and computed tomography (CT) tumour size in
18FDG
positron emission tomography (PET)/CT follow-up stu-
dies in oncologic patients are often assessed in tandem to
determine disease progression or regression. RECIST cri-
teria based on CT [1] are most frequently used, but criteria
based on the uptake of
18FDG are receiving increasing
attention [2,3]. With this, the demand for quantitative
monitoring of SUV has grown as the indications for per-
forming follow-up
18FDG PET/CT are expanding [4].
SUVmax measurements are more readily reproducible than
CT sizes in both pre- and post-treatment studies [5].
Currently available PET/CT software enables the use of
tools that can determine SUVmax by defining a ROI/VOI
both manually and automatically within one examination.
To our knowledge, none of the PET/CT manufacturers
offer a software suite that can measure two matching
uptakes in serial examinations automatically.
There are several studies on tumour delineation and
quantification in PET/CT [6-12]. New quantitative
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suggested in some papers [6,11]. But differences in ima-
ging parameters across PET centres have a negative
effect on semi-automatic methods’ performance [13,14].
Due to the increasing amount of examinations and the
quantification that can be done, standardization of PET
image acquisition and effective computer-aided quantifi-
cation is warranted.
A common clinical setting for PET/CT is the evaluation
of follow-up examinations after treatment or expectancy.
Manual measurement of SUVmax in single studies or
changes in serial studies can be time consuming, making it
difficult for clinicians and PET reviewers to follow-up all
SUVmax changes in serial studies in a comprehensive and
effective way. Studies with semi-automatic quantification
of SUVmax changes in serial examinations suggest registra-
tion of images and SUV measurements are accurate and
reliable [6,11]. Time saving qualities, or investigation of
the reproducibility of using a semi-automatic approach,
compared to manual reading of SUVmax has not been eli-
cited. The purpose of this study is to demonstrate these
qualities using a semi-automatic method for calculation of
SUVmax of an abnormal lesion in serial studies when a
region of interest (ROI) has been semi-automatically
defined in the PET image.
Materials and methods
Patients
Patients with lung cancer or lymphoma who had under-
gone two PET/CT studies between July 2008 and January
2010 at the Skåne University Hospital in Malmö, Sweden
were included retrospectively.
There were ten lung cancer patients and six lymphoma
patients. Diagnoses were verified with biopsy in all cases
except for one patient on which the diagnosis was based
on clinical findings. The patients had not been treated
with chemotherapy or radiation therapy for at least 6
months prior to the baseline examination. The time from
baseline examination to the follow-up examination varied
between 31 and 150 days. Follow-up examinations were
performed to evaluate tumour progression in five cases
and therapy response in eleven cases.
Pathological lesions with sharp contrast to surrounding
areas, no formation of a large conglomerate mass and
presence in both studies were selected. 16 patients (69%
men, age 56 ± 15 (mean ± SD)) with 26 pathological
lesions were included. Each patient had one to four
pathological lesions for manual and semi-automatic mea-
surement. The study was approved by the Research
Ethics Committee at Lund University.
Scan data
After 4-6 hours fast 4 MBq/kg of
18FDG was given
intravenously. The effective dose was 5-7 mSv for PET,
2-3 mSv for low-dose CT and 10-15 for diagnostic CT.
Data were acquired 60 min after injection and the
patients were scanned from head to the upper thigh
with the use of an integrated PET/CT system (Philips
Gemini TF). A diagnostic/low dose CT scan obtained
with the use of a standard protocol, 150 mAs/slice,
120 kV, a tube rotation time of 0.75 s per CT rotation,
a pitch of 0.9, and a slice thickness of 5 mm preceded
the PET scan covering the identical transverse field of
view (a 2 min emission scan per table position and 6-10
bed positions per patient).
The PET image data sets were reconstructed iteratively
with segmented correction for attenuation with use of
the CT data. CT images, PET images and co-registered
images were displayed by means of Philips workstation
and program. Reconstructed PET and CT images were
also transferred to a customized software developed for
semi-automatic measurements.
SUVmax measurements
Three readers did manual and semi-automatic analysis of
SUVmax on 26 pathological lesions. One of the readers
marked the 26 lesions in screenshots of coronal and trans-
axial PET images and these images were used during the
study to secure that all three readers were measuring the
same lesions with the manual and the semi-automatic
method. The time to measure SUVmax manually and semi-
automatically, after complete loading of the serial studies,
was recorded on all pathological lesions individually.
Manual method
Manual measurements were done on a Philips PET/CT
workstation (Philips Extended Brilliance Workspace,
PET/CT Application Suite v1.5 K). The readers identified
the lesions in both PET studies and used their most pre-
ferred software tool to determine the SUVmax. Readers
reported that they used the free-floating SUV search tool
and ROIs.
Semi-automatic method
Am e t h o dt om e a s u r eS U V max of a pathological lesion
present in two studies from the same patient was devel-
oped. Transaxial PET and CT images from the two stu-
dies were used as input to the program. The two CT
studies were automatically aligned by projecting the ske-
letons in the CT images on a 2D space. A rigid registra-
tion algorithm was used. CT images were reduced in size,
blurred, thresholded and then overlaid to compare pixels
with the formula: Σ(i, j)erf(i, j) = |IM1(i, j)-IM2(i, j)|
One of the images is repositioned and the formula is
applied again to calculate the pixel error. The process is
reiterated with less size reduction and blurring each time.
The reader marked an arbitrary pixel of a pathological
lesion in one of the two PET studies. After this manual
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ing lesion in the second PET study. The reader’sm a r k
in the first PET study has a corresponding location in
the first CT study, provided that PET and CT images
were correctly aligned from the PET/CT camera. The
corresponding location in the second CT study was
defined using the matching by the software and the cor-
responding location in the second PET study was
defined.
The volumetric segmentation of the pathological
lesions was made in the PET images. The reader’s mark
in the first PET study and the corresponding location in
the second PET study were used as seed points for the
segmentation using the graph-cut algorithm [15]. SUV-
max in the entire lesion was then calculated automati-
cally and the segmentations were presented to the
reader. Semi-automatic analysis was done on a standard
laptop computer (Figure 1).
Statistical analyses
Intraobserver reproducibility was analysed with Intraclass
correlation (ICC). A Bland-Altman analysis was used to
assess the level of agreement between the two methods.
Results
The Bland-Altman analysis indicates that the 95% limits
of agreement between manual and semi-automatic
assessment ranged from -2.67 to 1.29 (reader 1); -3.39 to
2.29 (reader 2); -2.21 to 1.18 (reader 3). The two methods
consistently provide similar measures for most of the
tumours. Limits of agreement ranged from ± 0.99 to ±
1.41 across the readers. Manual and semi-automatic
method agreed in all cases whether SUVmax had
increased or decreased between the serial studies. The
range of SUVmax values for the manual method was 2.4 -
19.8 and for the semi-automatic method 2.6 - 21.4.
ICCs of SUVmax readings between readers using the
semi-automatic method in the first and second study
were 1.00 (95% CI, 1.00-1.00) and 0.94 (95% CI, 0.89-
0.97) respectively. ICC of SUVmax readings between
readers using the manual method were 1.00 (95% CI,
1.00-1.00) and 0.95 (95% CI, 0.90-0.97) for the first and
second study respectively. Almost-perfect reproducibility
was thus obtained with both methods.
The average time to measure SUVmax changes in two
serial PET/CT examinations was significantly longer for
the manual method compared to the semi-automatic
method for all readers (Table 1). The semi-automatic
method is up to 4 - 5 times faster compared to the
manual method (Figure 2).
Discussion
Good agreement between the two methods was showed
with the Bland-Altman analysis. The somewhat wider
range of limits of agreement in reader 2 (± 1.41) seems
to be due to not finding the highest SUVmax with the
manual method within some large tumours with high
SUVmax. This resulted in a greater difference comparing
to the semi-automatic method. Both methods agreed
whether the SUVmax had increased or decreased in the
follow-up examination. The results of this study indicate
the feasibility of using semi-automatic method in serial
examinations.
Like other studies [5,6,9,10], the selection of tumours
was limited to small-medium sized tumours, which were
round, had a clear delineation on the CT scan and were
not part of large conglomerates, which produce a “bleed-
ing” effect on the PET image. The almost-perfect reprodu-
cibility obtained with both methods is likely dependent on
the properties of the pathological sites. The finding sup-
ports the findings in previous studies [5,6,9,10]. Clinical
reality provides many obstacles for semi-automatic
Figure 1 Flowchart of the semi-automatic process.
Table 1 Average time to measure changes in SUVmax between two serial examinations for manual and semi-automatic
methods and the difference between them
Manual Semi-automatic Difference (95% CI) p-value X times faster
Reader 1 53.7 s 10.5 s 43.2 (36.4-49.9) < 0.001 5
Reader 2 27.3 s 6.9 s 20.4 (13.6-27.1) < 0.001 4
Reader 3 47.5 s 9.5 s 38.1 (31.3-44.8) < 0.001 5
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sites can be best segmented by algorithms no matter the
form, size or location it has.
Readers were not instructed whether they should per-
form the semi-automatic segmentation in the first or
second study. In the feedback after measuring with both
methods, readers agreed it was easier to segment the
correct tumour of both examinations by selecting the
tumour on the examination, which had the smallest
size. Should the readers have been instructed only to
segment in the first or second scan regardless, the
results may have shown poorer segmentation quality.
Segmentation in the PET image has more advantages
than segmentation in CT. In the study it enabled seg-
mentation of lymphoma in the liver and in locations
where the lesion in CT was adjacent to soft tissue. Also,
the segmentation tool used did not adequately segment
the lesions in CT.
Manual delineation capabilities were intentionally left
out of the program in order to test the accuracy of
semi-automatic segmentation and in order to keep the
time of analysis to a minimum.
SUVmax was chosen over SUVmean due to clinical
praxis at our hospital when assessing PET/CT examina-
tions. Furthermore, research has shown SUVmax mea-
surements are readily reproducible between readers [5].
The program shows systematically higher SUVmax com-
pared with the manual method. This may be due to dif-
ferent filter settings between the PET/CT manufacturer
and the program. It is unlikely that all readers have sys-
tematically missed the “true” SUVmax with the program.
Conclusions
Good agreement was shown in absolute SUVmax mea-
surements between both methods. Almost-perfect repro-
ducibility was seen between three readers using both
semi-automatic and manual methods. Using semi-auto-
matic method reduces time to calculate SUVmax by up
to 5 times. The findings show feasibility of using semi-
automatic calculation of SUVmax in serial studies and
encourage further development of programs that accu-
rately segments more complex pathological sites.
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